The MONY Group of New York announced last week that David Thomas, CEO of IMS Health, a market research firm for the pharmaceuticals and healthcare industries, has been nominated to MONY's board of directors. Shareholders will vote on the nomination at the firm's annual shareholder meeting scheduled for May 15.
"While [Thomas'] work in the healthcare, pharmaceutical and technology industries is valuable, it is his executive and management experience that will help us in addressing today's challenging business issues," said Michael Roth, CEO of The MONY Group.
With approximately $55 billion in assets under management and administration, The MONY Group provides products and services in multiple asset management areas including mutual funds, annuities, life insurance, brokerage, business & estate planning, trusts and investment banking. The firm's member companies include The Advest Group, MONY Life Insurance Co., MONY Life Insurance Co. of America, Matrix Capital Markets Group, Enterprise Capital Management, U.S. Financial Life Insurance Co., Lebenthal & Co., MONY Securities Corp. and Trusted Securities Advisors Corp.
